C1 esterase inhibitor (human)
Orphan Drug Cold Chain RequiredFDA Approved
Contents
Description
C1 esterase inhibitor (human) is a purified plasma-derived concentrate used to treat acute angioedema attacks in patients with hereditary angioedema (HAE). It replaces the missing or dysfunctional C1-INH protein, helping to restore normal regulation of the complement system.
Indications & Therapeutic Use
Hereditary Angioedema
Global Availability (4 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source C1 esterase inhibitor (human) — GNH India
85 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Berinert 2000IU
500 IU/Ml 10MLvialsGermany
Berinert
EU
BERINERT 1500
1500 UNITkitCANADA
Berinert 500
500IUvialsSwitzerland
Berinert Iv
EU
Berinert Sc
EU
Cinryze
EU
HAEGARDA
2000 UNITkitCANADA
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
C1 esterase inhibitor (human)
| Generic Name | C1 esterase inhibitor (human) |
| Brands | 1 brand available |
| Active Ingredient | C1 esterase inhibitor |
| Drug Class | Hereditary Angioedema |
| Manufacturer | CSL Behring |
| Dosage Forms | Lyophilized powder for reconstitution |
| Medical Code | B06AC01 |
| Orphan Status | Yes — Orphan Drug |
| Cold Chain | Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved |
| Clinical Trial | NCT02581672 |
| Countries | 4 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations5 Validated Nodes